Edición de códigos

Próxima1 oct 2026 – 30 sept 2027

C86.60PróximaCódigo facturable y específico

Primary cutaneous CD30-positive T-cell proliferations not having achieved remission

C86 · Instrucciones de niveles superiores

Excludes 1

anaplastic large cell lymphoma, ALK negative (C84.7-)
anaplastic large cell lymphoma, ALK positive (C84.6-)
mature T/NK-cell lymphomas (C84.-)
other specified types of non-Hodgkin lymphoma (C85.8-)

Excludes 2 · 4

C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)

Excludes 2

Kaposi's sarcoma of lymph nodes (C46.3)
secondary and unspecified neoplasm of lymph nodes (C77.-)
secondary neoplasm of bone marrow (C79.52)
secondary neoplasm of spleen (C78.89)

Facturación y cobertura

La cobertura depende del pagador, el servicio y la política aplicable. Un código facturable no garantiza el pago.

Cuándo se exige ICD-10-CM

ICD-10-CM es obligatorio para los diagnósticos en reclamaciones estadounidenses sujetas a HIPAA desde el 1 de octubre de 2015.

Use la fecha del servicio en atención ambulatoria y profesional, y la fecha de alta en hospitalización. La atención anterior usa ICD-9-CM; cada código también debe ser válido en la fecha correspondiente.

Directrices oficiales de codificación → · CMS ↗

Consultar cobertura Medicare ↗

Primera aparición · 2024-10-01

Historial del código

Último cambio registrado · FY2025

ModificadoSin cambios

FY2025

Vigente desde 2024-10-01

Añadido

Primary cutaneous CD30-positive T-cell proliferations not having achieved remission

Código de diagnóstico facturable

CDC/NCHS · FY2025

Todas las ediciones (5)

Todas las ediciones	Vigente desde	Historial del código
FY2025	2024-10-01	Añadido
FY2025 · 04-01	2025-04-01	Sin cambios tabulares
FY2026	2025-10-01	Sin cambios tabulares
FY2026 · April	2026-04-01	Sin cambios tabulares
FY2027	2026-10-01	Sin cambios tabulares

Instrucciones del código

Inclusion terms

Lymphomatoid papulosis NOS
Lymphomatoid papulosis not having achieved remission
Lymphomatoid papulosis with failed remission
Primary cutaneous anaplastic large cell lymphoma NOS
Primary cutaneous anaplastic large cell lymphoma not having achieved remission
Primary cutaneous anaplastic large cell lymphoma with failed remission
Primary cutaneous CD30-positive large T-cell lymphoma NOS
Primary cutaneous CD30-positive large T-cell lymphoma not having achieved remission
Primary cutaneous CD30-positive large T-cell lymphoma with failed remission
Primary cutaneous CD30-positive T-cell proliferations NOS
Primary cutaneous CD30-positive T-cell proliferations with failed remission

Instrucciones de niveles superiores

Capítulos 2 · Neoplasms (C00-D49)

Note

Functional activity
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
Morphology [Histology]
Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
Primary malignant neoplasms overlapping site boundaries
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
Malignant neoplasm of ectopic tissue
Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)

Excludes 2

Kaposi's sarcoma of lymph nodes (C46.3)
secondary and unspecified neoplasm of lymph nodes (C77.-)
secondary neoplasm of bone marrow (C79.52)
secondary neoplasm of spleen (C78.89)

C86 · Other specified types of T/NK-cell lymphoma

Excludes 1

anaplastic large cell lymphoma, ALK negative (C84.7-)
anaplastic large cell lymphoma, ALK positive (C84.6-)
mature T/NK-cell lymphomas (C84.-)
other specified types of non-Hodgkin lymphoma (C85.8-)

C86.6 · Primary cutaneous CD30-positive T-cell proliferations

Inclusion terms

Lymphomatoid papulosis
Primary cutaneous anaplastic large cell lymphoma
Primary cutaneous CD30-positive large T-cell lymphoma

Historial oficial de conversión

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Fechas de vigencia 2024-10-01

Asignación anterior: C86.6

Códigos relacionados

Otras entradas de la misma categoría; no son sustitutos automáticos.

Código	Descripción	Categoría · se requiere mayor especificidad
C86.61	Primary cutaneous CD30-positive T-cell proliferations, in remission	Código facturable y específico

Los títulos e instrucciones oficiales se conservan en el idioma de origen. Fuentes oficiales ↗

Referencias desde otros códigos (1)

C84.Z · Other mature T/NK-cell lymphomas

Excludes 1 · primary cutaneous CD30-positive T-cell proliferations (C86.60)

C86.60PróximaCódigo facturable y específico

Primary cutaneous CD30-positive T-cell proliferations not having achieved remission

C86 · Instrucciones de niveles superiores

Excludes 1

anaplastic large cell lymphoma, ALK negative (C84.7-)
anaplastic large cell lymphoma, ALK positive (C84.6-)
mature T/NK-cell lymphomas (C84.-)
other specified types of non-Hodgkin lymphoma (C85.8-)

Excludes 2 · 4

C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)

Excludes 2

Kaposi's sarcoma of lymph nodes (C46.3)
secondary and unspecified neoplasm of lymph nodes (C77.-)
secondary neoplasm of bone marrow (C79.52)
secondary neoplasm of spleen (C78.89)

Facturación y cobertura

La cobertura depende del pagador, el servicio y la política aplicable. Un código facturable no garantiza el pago.

Cuándo se exige ICD-10-CM

ICD-10-CM es obligatorio para los diagnósticos en reclamaciones estadounidenses sujetas a HIPAA desde el 1 de octubre de 2015.

Directrices oficiales de codificación → · CMS ↗

Consultar cobertura Medicare ↗

Primera aparición · 2024-10-01

Historial del código

Último cambio registrado · FY2025

ModificadoSin cambios

FY2025

Vigente desde 2024-10-01

Añadido

Primary cutaneous CD30-positive T-cell proliferations not having achieved remission

Código de diagnóstico facturable

CDC/NCHS · FY2025

Todas las ediciones (5)

Todas las ediciones	Vigente desde	Historial del código
FY2025	2024-10-01	Añadido
FY2025 · 04-01	2025-04-01	Sin cambios tabulares
FY2026	2025-10-01	Sin cambios tabulares
FY2026 · April	2026-04-01	Sin cambios tabulares
FY2027	2026-10-01	Sin cambios tabulares

Instrucciones del código

Inclusion terms

Lymphomatoid papulosis NOS
Lymphomatoid papulosis not having achieved remission
Lymphomatoid papulosis with failed remission
Primary cutaneous anaplastic large cell lymphoma NOS
Primary cutaneous anaplastic large cell lymphoma not having achieved remission
Primary cutaneous anaplastic large cell lymphoma with failed remission
Primary cutaneous CD30-positive large T-cell lymphoma NOS
Primary cutaneous CD30-positive large T-cell lymphoma not having achieved remission
Primary cutaneous CD30-positive large T-cell lymphoma with failed remission
Primary cutaneous CD30-positive T-cell proliferations NOS
Primary cutaneous CD30-positive T-cell proliferations with failed remission

Instrucciones de niveles superiores

Capítulos 2 · Neoplasms (C00-D49)

Note

Functional activity
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
Morphology [Histology]
Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
Primary malignant neoplasms overlapping site boundaries
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
Malignant neoplasm of ectopic tissue
Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)

Excludes 2

Kaposi's sarcoma of lymph nodes (C46.3)
secondary and unspecified neoplasm of lymph nodes (C77.-)
secondary neoplasm of bone marrow (C79.52)
secondary neoplasm of spleen (C78.89)

C86 · Other specified types of T/NK-cell lymphoma

Excludes 1

anaplastic large cell lymphoma, ALK negative (C84.7-)
anaplastic large cell lymphoma, ALK positive (C84.6-)
mature T/NK-cell lymphomas (C84.-)
other specified types of non-Hodgkin lymphoma (C85.8-)

C86.6 · Primary cutaneous CD30-positive T-cell proliferations

Inclusion terms

Lymphomatoid papulosis
Primary cutaneous anaplastic large cell lymphoma
Primary cutaneous CD30-positive large T-cell lymphoma

Historial oficial de conversión

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Fechas de vigencia 2024-10-01

Asignación anterior: C86.6

Códigos relacionados

Otras entradas de la misma categoría; no son sustitutos automáticos.

Código	Descripción	Categoría · se requiere mayor especificidad
C86.61	Primary cutaneous CD30-positive T-cell proliferations, in remission	Código facturable y específico

Los títulos e instrucciones oficiales se conservan en el idioma de origen. Fuentes oficiales ↗

Referencias desde otros códigos (1)

C84.Z · Other mature T/NK-cell lymphomas

Excludes 1 · primary cutaneous CD30-positive T-cell proliferations (C86.60)